Tag: Pharmaceutical Manufacturing

Due to Poor Manufacturing Practices U.S. Marshals Seized Life Rising Corporation’ Production

fda office
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 300,000 containers of dietary supplements, including tablets, capsules, and teas from Life Rising Corporation. ...

PCI Expands its Flagship Manufacturing Centre

PCI Pharma Services (PCI) has announced further investment to expand its flagship manufacturing centre in Tredegar, Wales. The plan for the Tredegar site will double its highly potent tableting cap...

Rentschler Fill Solutions launched a fill and finish facility in Austria

pharma vial
Rentschler Fill Solutions GmbH, a contract development and manufacturing organization and expert in aseptic fill and finish services, officially inaugurated its new facility in Rankweil (Austria).

NEARMEDIC launched the first Russian facility for DNA testing reagents production

niarmedic_1
The full-cycle facility is to manufacture reactants for genetic person’s identification and establishment of filiation through DNA tests.

SID&GP presented the inspection overview of foreign pharma manufacturers

sid&gp
Mr. Vladislav Shestakov presented a review of the results of inspections of foreign pharmaceutical manufacturers at the PharmMedCirculation 2018 conference.

Ajinomoto Althea and OmniChem formed Ajinomoto Bio-Pharma Services

research
Ajinomoto Althea and OmniChem are integrating their businesses and operations as a unified CDMO, and changing their name to Ajinomoto Bio-Pharma Services.

PharmaBlock Sciences acquires a GMP manufacturing facility in China

pharma
PharmaBlock Sciences, an innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced that it has acquired a GMP compliant manufacturing facility in China.

Samsung Biologics third plant commenced production

samsung biologics
Samsung BioLogics announced that its Plant 3, the world’s largest single bio manufacturing plant, has become cGMP ready and started production after its successful validation.

Cambrex sets up a center of excellence for API clinical supply

cambrex
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms announced that it is to establish a center of ...

AGC Biologics will set up a new facility in Japan

test tube
AGC Biologics announced that it will establish a new state of the art process development and manufacturing facility at its CDMO facility in Chiba (Japan).

Kaneka begins a continuous GMP manufacturing

test tube
Kaneka Corporation have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore with commercial production under cGMP already underway.

Sanofi’s pharma plant in the Pyrenees will resume some operations

Sanofi
A month after being shut down over toxic pollution, Sanofi’s drug manufacturing plant in the Pyrenees has been authorised to resume certain operations starting mid-August.

Nacimbio expands R&D center for the development of substances

sintez
Increasing the production of medicines from its own substances is the medium term strategic goal of the Joint Stock Company Kurgan Society of Medical Preparations and Products Synthesis (part of Marathon Pharma and Nacimbio).

Novo Nordisk Pharmatech signs a distribution agreement with Signet

Novo Nordisk
Novo Nordisk Pharmatech has entered into an agreement with Signet Chemical for the distribution of their pharmaceutical range of quaternary ammonium compounds in India, Bangladesh and Sri Lanka.

West Pharmaceutical Services opens new facility in Ireland

west
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, announced the official opening of its new Waterford (Ireland) facility.

AGC will boost its GMP-compliant pharma production

chemistry
AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.